AcrobiosystemsLtd Balance Sheet Health
Financial Health criteria checks 5/6
AcrobiosystemsLtd has a total shareholder equity of CN¥2.6B and total debt of CN¥50.9M, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are CN¥2.8B and CN¥235.2M respectively. AcrobiosystemsLtd's EBIT is CN¥46.1M making its interest coverage ratio -0.8. It has cash and short-term investments of CN¥1.9B.
Key information
2.0%
Debt to equity ratio
CN¥50.91m
Debt
| Interest coverage ratio | -0.8x |
| Cash | CN¥1.85b |
| Equity | CN¥2.57b |
| Total liabilities | CN¥235.18m |
| Total assets | CN¥2.80b |
Recent financial health updates
No updates
Recent updates
AcrobiosystemsLtd's (SZSE:301080) Anemic Earnings Might Be Worse Than You Think
Nov 06
Investors Appear Satisfied With Acrobiosystems Co.,Ltd.'s (SZSE:301080) Prospects As Shares Rocket 27%
Oct 01Why We're Not Concerned About Acrobiosystems Co.,Ltd.'s (SZSE:301080) Share Price
Jul 15AcrobiosystemsLtd's (SZSE:301080) Weak Earnings Might Be Worse Than They Appear
May 02Financial Position Analysis
Short Term Liabilities: 301080's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥214.1M).
Long Term Liabilities: 301080's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥21.1M).
Debt to Equity History and Analysis
Debt Level: 301080 has more cash than its total debt.
Reducing Debt: 301080's debt to equity ratio has increased from 0% to 2% over the past 5 years.
Debt Coverage: 301080's debt is well covered by operating cash flow (262.6%).
Interest Coverage: 301080 earns more interest than it pays, so coverage of interest payments is not a concern.